These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 2115711)

  • 1. Effects of propranolol on GH responsiveness to repeated GH-releasing hormone stimulations in normal subjects.
    Arosio M; Losa M; Bazzoni N; Bochicchio D; Palmieri E; Nava C; Faglia G
    Acta Endocrinol (Copenh); 1990 Jun; 122(6):735-9. PubMed ID: 2115711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired inhibitory effects of somatostatin on growth hormone (GH)-releasing hormone stimulation of GH secretion after short term infusion.
    Kelijman M; Frohman LA
    J Clin Endocrinol Metab; 1990 Jul; 71(1):157-63. PubMed ID: 1973420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Galanin infusion partially restores the blunted growth hormone responses to repeated growth hormone releasing hormone stimuli in normal adults.
    Sartorio A; Spada A; Conti A; Grugni G; Morabito F; Faglia G
    J Endocrinol Invest; 1993 Feb; 16(2):95-8. PubMed ID: 7681861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GH responsiveness to repeated GHRH or hexarelin administration in normal adults.
    Sartorio A; Conti A; Ferrero S; Spada A; Faglia G
    J Endocrinol Invest; 1995 Oct; 18(9):718-22. PubMed ID: 8719303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The decrease in growth hormone (GH) response after repeated stimulation with GH-releasing hormone is partly caused by an elevation of somatostatin tonus.
    Reichardt B; Schrader M; Mojto J; Mehltretter G; Müller OA; Schopohl J
    J Clin Endocrinol Metab; 1996 May; 81(5):1994-8. PubMed ID: 8626871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Melatonin stimulates growth hormone secretion through pathways other than the growth hormone-releasing hormone.
    Valcavi R; Zini M; Maestroni GJ; Conti A; Portioli I
    Clin Endocrinol (Oxf); 1993 Aug; 39(2):193-9. PubMed ID: 8370132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of propranolol on growth hormone response to GH releasing hormone (GHRH 1-44) in the dog.
    Regnier A; Bret L; Morre M
    Res Vet Sci; 1992 Jan; 52(1):110-2. PubMed ID: 1553429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different GH responsiveness to repeated GHRH administration in normal children and adults.
    Sartorio A; Spada A; Morabito F; Faglia G
    J Endocrinol Invest; 1988 Nov; 11(10):727-9. PubMed ID: 3148001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Augmentation by propranolol of growth hormone-releasing hormone-(1-44)-NH2-induced growth hormone release in normal short and normal children.
    Chihara K; Kodama H; Kaji H; Kita T; Kashio Y; Okimura Y; Abe H; Fujita T
    J Clin Endocrinol Metab; 1985 Aug; 61(2):229-33. PubMed ID: 2989315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth hormone releasing hormone 1-44 NH2 and 1-40 OH levels in normal subjects during growth hormone stimulation tests.
    Page MD; Dieguez C; Valcavi R; Koppeschaar HP; Scanlon MF
    Clin Endocrinol (Oxf); 1994 Jan; 40(1):97-102. PubMed ID: 8306488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth hormone (GH) responsiveness to combined administration of arginine and GH-releasing hormone does not vary with age in man.
    Ghigo E; Goffi S; Nicolosi M; Arvat E; Valente F; Mazza E; Ghigo MC; Camanni F
    J Clin Endocrinol Metab; 1990 Dec; 71(6):1481-5. PubMed ID: 2229304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arginine stimulates growth hormone secretion by suppressing endogenous somatostatin secretion.
    Alba-Roth J; Müller OA; Schopohl J; von Werder K
    J Clin Endocrinol Metab; 1988 Dec; 67(6):1186-9. PubMed ID: 2903866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Theophylline blunts the GH-response to growth hormone releasing hormone in normal subjects.
    Losa M; Huss R; König A; Müller OA; von Werder K
    Acta Endocrinol (Copenh); 1986 Aug; 112(4):473-80. PubMed ID: 3092529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute hyperglycemia and activation of the beta-adrenergic system exhibit synergistic inhibitory actions on growth hormone (GH) releasing hormone-induced GH release.
    Park C; Yang I; Woo J; Kim S; Kim J; Kim Y; Park S
    Eur J Endocrinol; 2003 Jun; 148(6):635-40. PubMed ID: 12773135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pyridostigmine blocks the inhibitory effect of glucocorticoids on growth hormone-releasing hormone stimulated growth hormone secretion in normal man.
    Giustina A; Girelli A; Doga M; Bodini C; Bossoni S; Romanelli G; Wehrenberg WB
    J Clin Endocrinol Metab; 1990 Sep; 71(3):580-4. PubMed ID: 2118535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arginine and growth hormone-releasing hormone restore the blunted growth hormone-releasing activity of hexarelin in elderly subjects.
    Arvat E; Gianotti L; Grottoli S; Imbimbo BP; Lenaerts V; Deghenghi R; Camanni F; Ghigo E
    J Clin Endocrinol Metab; 1994 Nov; 79(5):1440-3. PubMed ID: 7962341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new test for the diagnosis of growth hormone deficiency due to primary pituitary impairment: combined administration of pyridostigmine and growth hormone-releasing hormone.
    Ghigo E; Imperiale E; Boffano GM; Mazza E; Bellone J; Arvat E; Procopio M; Goffi S; Barreca A; Chiabotto P
    J Endocrinol Invest; 1990 Apr; 13(4):307-16. PubMed ID: 2115060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of cholinergic tone by pyridostigmine reverses the inhibitory effect of corticotropin-releasing hormone on the growth hormone-releasing hormone-induced growth hormone secretion.
    Corsello SM; Tofani A; Della Casa S; Sciuto R; Rota CA; Colasanti S; Bini A; Barini A; Barbarino A
    Acta Endocrinol (Copenh); 1992 Feb; 126(2):113-6. PubMed ID: 1543015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Galanin infusion restores the blunted GH responses to GHRH administration during GH treatment in children with constitutional growth delay.
    Sartorio A; Conti A; Monzani M; Faglia G
    J Endocrinol Invest; 1995 Feb; 18(2):109-12. PubMed ID: 7543124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth hormone (GH) and prolactin responses to repetitive administration of GH-releasing hormone in acromegaly.
    Losa M; Schopohl J; König A; Müller OA; von Werder K
    J Clin Endocrinol Metab; 1986 Aug; 63(2):475-80. PubMed ID: 3088026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.